Lyell Immunopharma (LYEL) FY 2025 Conference June 11, 2025 10:00 AM ET Speaker0 Great. Good morning, everyone. Thank you so much for joining us. I'm Salveen Richter, biotechnology analyst at Goldman Sachs. I'm really pleased to have with me the Lyle team. So next to me is Lynn Sealy, President and CEO of the company, and Charlie Newton, CFO. So maybe to start here for both of you, could you give us an overview of where your programs currently stand today and your key focus areas heading into the half of the ...